The spine industry should expect to see a steady inflow of new products designed for the non-fusion surgical space, according to an analysis report released by Frost & Sullivan.
The report indicates that, over the next five years, the advancement in non-fusion spinal surgery techniques as well as evidence about the negative aspects of spinal fusion will prompt an expansion of non-fusion products. The analysis includes a study of crucial market drivers, challenges and trends impacting spine device manufacturers today.
Additionally, the report includes pricing analysis and a discussion of the market share and competitor structure.
Read the Frost & Sullivan release on the spine industry analysis.
Read other coverage on spine device companies:
- Boston Scientific Receives FDA Approval for Spinal Cord Stimulation Lead Splitters
- WSJ: Spine Device Manufacturers Feel the Pressure From Insurance Companies
- TranS1 Releases New System for Lumbar Fusion
The report indicates that, over the next five years, the advancement in non-fusion spinal surgery techniques as well as evidence about the negative aspects of spinal fusion will prompt an expansion of non-fusion products. The analysis includes a study of crucial market drivers, challenges and trends impacting spine device manufacturers today.
Additionally, the report includes pricing analysis and a discussion of the market share and competitor structure.
Read the Frost & Sullivan release on the spine industry analysis.
Read other coverage on spine device companies:
- Boston Scientific Receives FDA Approval for Spinal Cord Stimulation Lead Splitters
- WSJ: Spine Device Manufacturers Feel the Pressure From Insurance Companies
- TranS1 Releases New System for Lumbar Fusion